This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Aventis Pharma S.a., Hoechst Marion Roussel, Roussel Uclaf. Active years: 1994-2002.
Company Filing History:
1 out of 377 
1 out of 236 
1 out of 854 Years Active: 1994-2002
Title: Jacques Scholl: Innovator in Pharmaceutical Chemistry
Introduction
Jacques Scholl is a notable inventor based in Romainville, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work has had a lasting impact on the development of various pharmaceutical compounds.
Latest Patents
Among his latest patents, Jacques Scholl has developed a method for preparing 4-(3-pyridinyl)-1H-imidazole and the intermediates used. He has also created a method for isomerizing the 10-methyl radical of erythromycin derivatives. These innovations showcase his expertise in synthesizing complex chemical structures.
Career Highlights
Throughout his career, Jacques Scholl has worked with prominent companies in the pharmaceutical industry, including Roussel Uclaf and Aventis Pharma S.A. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.
Collaborations
Jacques Scholl has collaborated with esteemed colleagues such as Jacques Lagouardat and Raphael Bouchet. These partnerships have fostered a collaborative environment that has led to innovative solutions in pharmaceutical chemistry.
Conclusion
Jacques Scholl's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the industry and inspire future innovations.